<VariationArchive RecordType="classified" VariationID="495062" VariationName="NM_006516.4(SLC2A1):c.1033_1042del (p.Ala345fs)" VariationType="Deletion" Accession="VCV000495062" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-11" DateCreated="2018-03-04" MostRecentSubmission="2022-12-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="486609" VariationID="495062">
      <GeneList>
        <Gene Symbol="SLC2A1" FullName="solute carrier family 2 member 1" GeneID="6513" HGNC_ID="HGNC:11005" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42925353" stop="42958868" display_start="42925353" display_stop="42958868" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43391045" stop="43424846" display_start="43391045" display_stop="43424846" Strand="-" />
          </Location>
          <OMIM>138140</OMIM>
          <Haploinsufficiency last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006516.4(SLC2A1):c.1033_1042del (p.Ala345fs)</Name>
      <CanonicalSPDI>NC_000001.11:42928963:CACAACCCGCCA:CA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p34.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42928964" stop="42928973" display_start="42928964" display_stop="42928973" variantLength="10" positionVCF="42928963" referenceAlleleVCF="GCACAACCCGC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43394635" stop="43394644" display_start="43394635" display_stop="43394644" variantLength="10" positionVCF="43394634" referenceAlleleVCF="GCACAACCCGC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A345fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.43394637_43394646del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.43394637_43394646del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.42928966_42928975del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.42928966_42928975del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008232.1" sequenceAccession="NG_008232" sequenceVersion="1" change="g.35204_35213del">
            <Expression>NG_008232.1:g.35204_35213del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006516.4" sequenceAccession="NM_006516" sequenceVersion="4" change="c.1033_1042del" MANESelect="true">
            <Expression>NM_006516.4:c.1033_1042del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006507.2" sequenceAccession="NP_006507" sequenceVersion="2" change="p.Ala345fs">
            <Expression>NP_006507.2:p.Ala345fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1132" sequenceAccession="LRG_1132">
            <Expression>LRG_1132:g.35204_35213del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658683134" DB="ClinGen" />
        <XRef Type="rs" ID="1553155973" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006516.4(SLC2A1):c.1033_1042del (p.Ala345fs) AND Encephalopathy due to GLUT1 deficiency" Accession="RCV000585705" Version="2">
        <ClassifiedConditionList TraitSetID="5230">
          <ClassifiedCondition DB="MedGen" ID="C4551966">Encephalopathy due to GLUT1 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-10-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-10-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-03-04" MostRecentSubmission="2022-12-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="5230" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1929" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GLUT1 deficiency syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLUT1 deficiency syndrome 1, infantile onset, severe</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">De Vivo disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucose transport defect, blood-brain barrier</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucose transporter protein syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Encephalopathy due to GLUT1 deficiency</ElementValue>
                <XRef ID="MONDO:0011724" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GLUT1DS1</ElementValue>
                <XRef Type="MIM" ID="606777" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS) is now known to be a continuum that includes the classic phenotype as well as paroxysmal exercise-induced dyskinesia and epilepsy (previously known as dystonia 18 [DYT18]) and paroxysmal choreoathetosis with spasticity (previously known as dystonia 9 [DYT9]), atypical childhood absence epilepsy, myoclonic astatic epilepsy, and paroxysmal non-epileptic findings including intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia. The classic phenotype is characterized by infantile-onset seizures, delayed neurologic development, acquired microcephaly, and complex movement disorders. Seizures in classic early-onset Glut1 DS begin before age six months. Several seizure types occur: generalized tonic or clonic, focal, myoclonic, atypical absence, atonic, and unclassified. In some infants, apneic episodes and abnormal episodic eye-head movements similar to opsoclonus may precede the onset of seizures. The frequency, severity, and type of seizures vary among affected individuals and are not related to disease severity. Cognitive impairment, ranging from learning disabilities to severe intellectual disability, is typical. The complex movement disorder, characterized by ataxia, dystonia, and chorea, may occur in any combination and may be continuous, paroxysmal, or continual with fluctuations in severity influenced by environmental factors such as fasting or with infectious stress. Symptoms often improve substantially when a ketogenic diet is started.</Attribute>
                <XRef ID="NBK1430" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301603</ID>
                <ID Source="BookShelf">NBK1430</ID>
              </Citation>
              <XRef ID="71277" DB="Orphanet" />
              <XRef ID="C4551966" DB="MedGen" />
              <XRef ID="MONDO:0011724" DB="MONDO" />
              <XRef Type="MIM" ID="606777" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1359166" SubmissionDate="2017-11-15" DateLastUpdated="2022-12-11" DateCreated="2018-03-04">
        <ClinVarSubmissionID localKey="23_October 2017|OMIM:606777" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000693469" DateUpdated="2022-12-11" DateCreated="2018-03-04" Type="SCV" Version="2" SubmitterName="Center of Genomic medicine, Geneva, University Hospital of Geneva" OrgID="505593" OrganizationCategory="laboratory" OrgAbbreviation="GenMed_GVA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshift variant (deletion of 10 nucleotides) in the SLC2A1 gene was identified in a young female patient with generalized development delay (psychomotor and language) and focal epilepsy</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC2A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.(Ala345Profs*4)</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006516.2:c.1033_1042del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606777" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Genome_Clinic_of_Geneva_November2017</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1359166" TraitType="Disease" MappingType="XRef" MappingValue="606777" MappingRef="OMIM">
        <MedGen CUI="C4551966" Name="Encephalopathy due to GLUT1 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

